VTGN — VISTAGEN THERAPEUTICS INC

Ownership history in STEMPOINT CAPITAL LP  ·  9 quarters on record

This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in VISTAGEN THERAPEUTICS INC (VTGN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.46% (2024 Q1)
Avg. % of fund
1.55%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 616,749 -1,871,936 -75.2% 0.02% $142K $0.66
2025 Q3 ADDED 2,488,685 +75,431 +3.1% 1.55% $7.7M $3.55
2025 Q2 ADDED 2,413,254 +46,700 +2.0% 1.32% $4.1M $2.00
2025 Q1 ADDED 2,366,554 +38,062 +1.6% 1.63% $5.1M $2.50
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    VTGN price (monthly, adj. close)

Other funds also holding VTGN

As of 2025 Q4 — sorted by position size

LUMINUS MANAGEMENT LLC 3Y 7Y 0.2% TCG Crossover Management, LLC 3Y 0.06% ORBIMED ADVISORS LLC 3Y 7Y 0.04% Seven Fleet Capital Management LP 0.03% ADAR1 Capital Management, LLC 0.03% AdvisorShares Investments LLC 3Y 0.03% Ikarian Capital, LLC 3Y 0.03% Persistent Asset Partners Ltd 0.01% ADAR1 Capital Management, LLC 0.01% OCCUDO QUANTITATIVE STRATEGIES LP 3Y 0.0%
← Back to STEMPOINT CAPITAL LP Holdings